Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
This antibody is covered by our Worry-Free Guarantee.

Figure:
(A) Schematic structure of caspase-8 and its cleavage products as detected by anti-caspase-8 (12F5). The antibody is directed against the p18 subunit and detects procaspase-8 (p55/54), the intermediate cleavage products of 43kD and 41kD and the p18 active subunit of caspase-8.
(B) Detection of Fas ligand-induced caspase-8 processing and activation in human Jurkat cells.
Method: Jurkat cells were treated with Fas ligand (100ng/ml). After the indicated time points cell lysates were prepared and separated on a 12.5% SDS-PAGE (2×106 cells/lane) under reducing conditions. Proteins were immunoblotted with anti-caspase-8 12F5 (1µg/ml). Following incubation with peroxidase-conjugated secondary antibodies caspase-8 processing was detected by enhanced chemoluminescent staining. The open arrowhead indicates the two isoforms of procaspase-8 (caspase-8/a and caspase-8/b), which are cleaved into the intermediate forms p43 and p41 and finally processed to the active p18 subunit (filled arrowheads).

Product Details
Alternative Name |
FLICE |
---|---|
Application |
IHC (FS), IP, WB |
Clone |
12F5 |
Crossreactivity |
Does not cross-react with mouse caspase-8. |
Formulation |
Liquid. In 0.15M PBS, pH 7.2, containing 1% BSA and 0.01% thimerosal. |
Host |
Mouse |
Immunogen |
Recombinant human caspase-8. |
Isotype |
IgG2b |
Purity Detail |
Protein G-affinity purified. |
Recommendation Dilutions/Conditions |
Western Blot (1:100)Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application. |
Species Reactivity |
Human |
Specificity |
Recognizes procaspase-8 and active caspase-8. Detects procaspase-8 (p55/54), the intermediate cleavage products (p43/41) and the p18 active subunit of caspase-8 by Western blot. |
UniProt ID |
Q14790 |
Worry-free Guarantee |
This antibody is covered by our Worry-Free Guarantee. |
Handling & Storage
Handling |
Avoid freeze/thaw cycles. |
---|---|
Long Term Storage |
+4°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- The cancer-associated SF3B1K700E spliceosome mutation confers enhanced sensitivity to BV-6-induced cytotoxicity: Roets, L. E., Blayney, J. K., et al.; Cell Death Dis. 16, 476 (2025), Abstract
- The Selective 3-MST Inhibitor I3MT-3 Works as a Potent Caspase-1 Inhibitor: Otani, K., Komatsu, R., et al.; Int. J. Mol. Sci. 26, 2237 (2025), Abstract
- NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation: Sundaram, B., Pandian, N., et al.; Cell 187, 4061 (2024), Abstract
- The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis: Holloway, J., Seeley, A., et al.; Cell Death Dis. 15, 40 (2024), Application(s): WB, Abstract
- Trauma-associated extracellular histones mediate inflammation via a MYD88-IRAK1-ERK signaling axis and induce lytic cell death in human adipocytes: Roos, J., Zinngrebe, J., et al.; Cell Death Dis. 15, 285 (2024), Abstract
- Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency: Oda, H., Manthiram, K., et al.; Nat. Immunol. 25, 764 (2024), Abstract
- Classical apoptotic stimulus, staurosporine, induces lytic inflammatory cell death, PANoptosis: Sarkar, R., Choudhury, S. M., et al.; J. Biol. Chem. 300, 107676 (2024), Abstract
- A comparative study of apoptosis, pyroptosis, necroptosis, and PANoptosis components in mouse and human cells: Choudhury, S. M., Sarkar, R., et al.; PLoS One 19, e0299577 (2024), Abstract
- Anthrax lethal toxin and tumor necrosis factor-α synergize on intestinal epithelia to induce mouse death: X. Gao, et al.; Protein Cell 15, 135 (2024), Abstract
- Caspase-8 activation by cigarette smoke induces pro-inflammatory cell death of human macrophages exposed to lipopolysaccharide: Cristaldi, M., Buscetta, M., et al.; Cell Death Dis. 14, 773 (2023), Abstract
- The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8).: Coppola, V., Marino, I., et al.; Autophagy 19, 2733 (2023), Reactant(s): Human, Abstract
- Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells.: Wächter, S., Roth, S., et al.; Life (Basel) 13, (2023), Application(s): WB, Abstract
- NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs.: Sundaram, B., Pandian, N., et al.; Cell 186, 2783 (2023), Application(s): IP / Reactant(s): Human, Abstract
- The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling: Anand, S., Nedeva, C., et al.; Cell Death Dis. 14, 828 (2023), Abstract
- Evaluation of Caspase Activation to Assess Innate Immune Cell Death: Han, J. H., Tweedell, R. E., et al.; J. Vis. Exp. , (2023), Abstract
- The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer: R. Mandal, et al.; Cell. Mol. Life Sci. 79, 597 (2022), Abstract
- Human LUBAC deficiency leads to autoinflammation and immunodeficiency by dysregulation in TNF-mediated cell death: Oda, H., Manthiram, K., et al.; medRxiv , (2022), Reactant(s): Human
- Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology.: Mall, R., Bynigeri, R. R., et al.; NAR Cancer 4, zcac033 (2022), Application(s): WB / Reactant(s): Human, Abstract
- ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection.: Karki, R., Lee, S., et al.; Sci. Immunol. 7, eabo6294 (2022), Application(s): WB, Abstract
- Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells: Planès, R., Pinilla, M., et al.; Mol. Cell 82, 2385 (2022), Abstract
- Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response.: Schmitt, M., Gallistl, J., et al.; Cancers (Basel) 14, (2022), Application(s): WB / Reactant(s): Human, Abstract
- Proteasome inhibition triggers the formation of TRAIL receptor 2 platforms for caspase-8 activation that accumulate in the cytosol: C.T. Hellwig, et al.; Cell Death Differ. 29, 147 (2022), Abstract
- Direct cleavage of caspase-8 by herpes simplex virus 1 tegument protein US11: M.M. Pizzo, et al.; Sci. Rep. 12, 12317 (2022), Abstract
- Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth: R.K.S. Malireddi, et al.; Immunohorizons 5, 568 (2021), Application(s): WB, Abstract
- TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.: Starheim, K. K., Hella, H., et al.; Oncotarget 12, 2158 (2021), Application(s): WB / Reactant(s): Human, Abstract
- Smac-mimetics reduce numbers and viability of human osteoclasts.: Starheim, K. K., Nonstad, U., et al.; Cell Death Discov. 7, 36 (2021), Application(s): WB, Abstract
- Exploring the MEN1 dependent modulation of caspase 8 and caspase 3 in human pancreatic and murine embryo fibroblast cells: N. Wagener, et al.; Apoptosis , (2021), Abstract
- Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer: Crawford, N., Stott, K. J., et al.; Mol. Cancer Ther. 20, 1627 (2021), Abstract
- Selective HSP90β inhibition results in TNF and TRAIL mediated HIF1α degradation: Heck, A. L., Mishra, S., et al.; Immunobiology 226, 152070 (2021), Abstract
- Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation: Douglas, T., Saleh, M., et al.; J. Biol. Chem. 295, 5216 (2020), Abstract
- A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis: Humphreys, L. M., Fox, J. P., et al.; EMBO Rep. 21, e49254 (2020), Abstract
- USP22 controls necroptosis by regulating receptor-interacting protein kinase 3 ubiquitination: J. Roedig, et al.; EMBO Rep. 2020, e50163 (2020), Application(s): IP, Abstract
- The Covalent CDK7 Inhibitor THZ1 Enhances Temsirolimus-Induced Cytotoxicity via Autophagy Suppression in Human Renal Cell Carcinoma: P.M. Chow, et al.; Cancer Lett. 471, 27 (2020), Abstract
- Post-translational Modification of OTULIN Regulates Ubiquitin Dynamics and Cell Death.: Saleh, M., Douglas, T., et al.; Cell Rep. 29, 3652 (2019), Reactant(s): Human, Abstract
- Cigarette smoke inhibits the NLRP3 inflammasome and leads to caspase-1 activation via the TLR4-TRIF-caspase-8 axis in human macrophages: M. Buscetta, et al.; FASEB J. 34, 1819 (2019), Abstract — Full Text
- Hsp60 and IL-8 axis promotes apoptosis resistance in cancer.: Kumar, S., O’Malley, J., et al.; Br. J. Cancer 121, 934 (2019), Reactant(s): Human, Abstract
- BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity: A.M. Heijink, et al.; Nat. Commun. 10, 100 (2019), Application(s): WB, Abstract — Full Text
- Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T-cell Lymphoma: Salva, K. A., Kim, Y. H., et al.; Photochem. Photobiol. 94, 1058 (2018), Abstract
- BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1β Maturation in Macrophages: D. Chauhan, et al.; Cell Rep. 25, 2354 (2018), Abstract
- Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism.: Lincoln, F. A., Imig, D., et al.; Cell Death Dis. 9, 1112 (2018), Application(s): IP, WB, Abstract
- Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations: S.C. Lee, et al.; Cancer Cell 34, 225 (2018), Abstract
- The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation: I. Faraoni, et al.; Cancer Lett. 423, 127 (2018), Reactant(s) Human, Abstract
- PU.1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expression.: Torbett, B. E., Frese, S., et al.; Cell Death Differ. 24, 866 (2017), Reactant(s): Human, Abstract
- The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3: Gaidt, M. M., Ebert, T. S., et al.; Cell 171, 1110 (2017), Abstract
- hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma.: Flørenes, V. A., Prasmickaite, L., et al.; Cell Death Discov. 2, 16081 (2016), Application(s): WB / Reactant(s): Mouse, Abstract
- Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome: Moriwaki, K., Chan, F. K., et al.; J. Biol. Chem. 291, 5948 (2016), Abstract
- Intrinsic and chemo-sensitizing activity of SMAC-mimetics on high-risk childhood acute lymphoblastic leukemia: Schirmer, M., Trentin, L., et al.; Cell Death Dis. 7, e2052 (2016), Abstract
- Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells: Bartee, M. Y., Dunlap, K. M., et al.; Clin. Lymphoma Myeloma Leuk. 16, 203 (2016), Abstract
- Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide.: Murphy, B. M., Rehm, M., et al.; Oncotarget 7, 61295 (2016), Application(s): WB, Abstract
- Cellular IAP proteins and LUBAC differentially regulate necrosome-associated RIP1 ubiquitination: M.C. de Almagro, et al.; Cell Death Dis. 6, e1800 (2015), Application(s): Immunoprecipitation, Abstract — Full Text
- Intestinal genetic inactivation of caspase-8 diminishes migration of enterocytes: E. Kaemmerer, et al.; World J Gastroenterol 21, 4499 (2015), Application(s): Western Blot, Abstract — Full Text
- Multiple mechanisms mediate resistance to sorafenib in urothelial cancer.: Schulz, W. A., Schmitz, I., et al.; Int. J. Mol. Sci. 15, 20500 (2014), Reactant(s): Human, Abstract
- TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation: Lehnert, C., Weiswange, M., et al.; J. Immunol. 193, 4021 (2014), Abstract
- Up-regulation of Bcl-2 during adipogenesis mediates apoptosis resistance in human adipocytes: S.A. Nagel, et al.; Mol. Cell Endocrinol. 382, 368 (2014), Application(s): WB using human cell lysates, Abstract
- Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer: J.S. Riley, et al.; Cell Death Dis. 4, e951 (2013), Application(s): WB using human cell lysates, Abstract — Full Text
- Vorinostat/SAHA-induced apoptosis in malignant mesothelioma is FLIP/caspase 8-dependent and HR23B-independent: J.L. Hurwitz, et al.; Eur. J. Cancer 48, 1096 (2012), Application(s): WB using human cell and tissue lysates, Abstract
- Cathepsin D primes caspase-8 activation by multiple intra-chain proteolysis: S. Conus, et al.; J. Biol. Chem. 287, 21142 (2012), Application(s): WB using human cell lysates, Abstract — Full Text
- A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils: B. Geering, et al.; Blood 117, 5953 (2011), Application(s): WB using human neutrophil lysates, Abstract — Full Text
- GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation: K. Moriwaki, et al.; J. Biol. Chem. 286, 43123 (2011), Application(s): WB using human cell lysates, Abstract — Full Text
- Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma: B. Gillissen, et al.; J. Cell Biol. 188, 851 (2010), Abstract
- Caspase 8 and menin expressions are not correlated in human parathyroid tumors.: Yu, D., Wada, S., et al.; Endocr. J. 57, 825 (2010), Reactant(s): Human, Abstract
- The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases: M. Rebsamen, et al.; Cell Death Differ. 15, 1804 (2008), Abstract
- The prevention of spontaneous apoptosis of follicular lymphoma B cells by a follicular dendritic cell line: involvement of caspase-3, caspase-8 and c-FLIP: J.J. Goval, et al.; Haematologica 93, 1169 (2008), Application(s): WB using human follicular lymphoma lysate, Abstract — Full Text
- Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia: Yang, J., Epling-Burnette, P. K., et al.; Blood 111, 1610 (2008), Abstract
- A Protective Role for the Human SMG-1 Kinase against Tumor Necrosis Factor-α-induced Apoptosis: V. Oliveira, et al.; J. Biol. Chem. 283, 13174 (2008), Abstract
- Trypanosoma cruzi posttranscriptionally up-regulates and exploits cellular FLIP for inhibition of death-inducing signal: Hashimoto, M., Nakajima-Shimada, J., et al.; Mol. Biol. Cell 16, 3521 (2005), Abstract
- Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines: Zoli, W., Ulivi, P., et al.; Breast Cancer Res. 7, R681 (2005), Abstract
- Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells: G. Strauss, et al.; J. Immunol. 171, 1172 (2003), Abstract — Full Text
- Role of Smac in human leukaemic cell apoptosis and proliferation.: Jia, L., Newland, A. C., et al.; Oncogene 22, 1589 (2003), Application(s): WB / Reactant(s): Human, Abstract
- An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis: Y. Kim, et al.; J. Biol. Chem. 277, 22320 (2002), Abstract — Full Text
- Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway: D. Siegmund, et al.; J. Biol. Chem. 276, 32585 (2001), Abstract — Full Text
- Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax: L. Jia, et al.; BBRC 283, 1037 (2001), Abstract
- Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD): H. Wajant, et al.; J. Biol. Chem. 275, 24357 (2000), Abstract — Full Text
- IL-10 induces apoptosis in human monocytes involving the CD95 receptor/ligand pathway: M. Schmidt, et al.; Eur. J. Immunol. 30, 1769 (2000), Abstract
- P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death: D. Ferrari, et al.; FEBS Lett. 447, 71 (1999), Abstract
- Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction: S. Wesselborg, et al.; Blood 93, 3053 (1999), Abstract — Full Text
- Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32): M. Bitzer, et al.; J. Virol. 73, 702 (1999), Abstract — Full Text
- Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis: D. Ferrari, et al.; J. Exp. Med. 188, 979 (1998), Abstract — Full Text
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form